Overview

Quetiapine Treatment for Pediatric Delirium

Status:
Withdrawn

Trial end date:
2020-03-02

Target enrollment:

Participant gender:

Summary

This is a prospective, double-blind, randomized controlled trial to begin determining the efficacy of quetiapine as a treatment for pediatric delirium in patients admitted to the pediatric intensive care unit (PICU)

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Medical College of Wisconsin

Treatments:

Quetiapine Fumarate